Synonyms: WCK-5107 | WCK5107
Compound class:
Synthetic organic
Comment: Zidebactam (WCK 5107) is a novel β-lactamase inhibitor [1-2]. It was developed for the treatment of serious infections caused by highly drug-resistant Gram-negative pathogens.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
[(2S,5R)-7-oxo-2-[[[(3R)-piperidine-3-carbonyl]amino]carbamoyl]-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate |
International Nonproprietary Names ![]() |
|
INN number | INN |
10006 | zidebactam |
Synonyms ![]() |
WCK-5107 | WCK5107 |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
Zidebactam | Zidebactam + Cefepime |
Other databases | |
GtoPdb PubChem SID | 405560315 |
PubChem CID | 77846445 |
Search Google for chemical match using the InChIKey | YCZPXRQPDCXTIO-BBBLOLIVSA-N |
Search Google for chemicals with the same backbone | YCZPXRQPDCXTIO |
Search PubMed clinical trials | zidebactam |
Search PubMed titles | zidebactam |
Search PubMed titles/abstracts | zidebactam |
UniChem Compound Search for chemical match using the InChIKey | YCZPXRQPDCXTIO-BBBLOLIVSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YCZPXRQPDCXTIO-BBBLOLIVSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Zidebactam (links to external site)
Cat. No. HY-120859 |